Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid Arthritis

OBJECTIVES: This study aims to examine the effects of tocilizumab therapy on serum levels of interleukin (IL)-33 and IL-6 in rheumatoid arthritis (RA) patients. PATIENTS AND METHODS: Interleukin-33 and IL-6 levels in serum samples from 83 RA patients (10 males, 73 females; mean age 51.9 years; range...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arch Rheumatol
Autors principals: CHOI, In Ah, LEE, Sang Jin, PARK, Won, PARK, Sung Hwan, SHIM, Seung-cheol, BAEK, Han Joo, YOO, Dae-Hyun, KIM, Hyun Ah, LEE, Soo Kon, LEE, Yun Jong, PARK, Young Eun, CHA, Hoon-Suk, LEE, Eun Young, LEE, Eun Bong, SONG, Yeong Wook
Format: Artigo
Idioma:Inglês
Publicat: Turkish League Against Rheumatism 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6409174/
https://ncbi.nlm.nih.gov/pubmed/30874247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5606/ArchRheumatol.2018.6753
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars